ASP Isotopes (ASPI) Cash & Equivalents (2021 - 2026)

ASP Isotopes' Cash & Equivalents history runs 6 years deep, the most recent figure standing at $207.3 million for Q1 2026.

• In Q1 2026, Cash & Equivalents rose 270.4% year-over-year to $207.3 million; the TTM figure through Mar 2026 stood at $207.3 million (up 270.4% YoY), while the FY2025 annual figure was $279.6 million, up 351.72% from the prior year.
• Cash & Equivalents was $207.3 million for Q1 2026 at ASP Isotopes, down from $279.6 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $279.6 million in Q4 2025 to a low of $431565.0 in Q3 2022.
• Historically, Cash & Equivalents has averaged $54.0 million across 5 years, with a median of $23.9 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Cash & Equivalents retreated 19.11% in 2022, then jumped 2155.18% in 2024.
• A 5-year view of Cash & Equivalents shows it stood at $2.4 million in 2022, then soared by 231.0% to $7.9 million in 2023, then soared by 682.63% to $61.9 million in 2024, then jumped by 351.72% to $279.6 million in 2025, then declined by 25.85% to $207.3 million in 2026.
• The last three Cash & Equivalents figures came in at $207.3 million (Q1 2026), $279.6 million (Q4 2025), and $113.9 million (Q3 2025), per Business Quant data.